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Dietary potassium deficiency, common in modern
diets, raises blood pressure and enhances salt sensi-
tivity. Potassium homeostasis requires a molecular
switch in the distal convoluted tubule (DCT), which
fails in familial hyperkalemic hypertension (pseudo-
hypoaldosteronism type 2), activating the thiazide-
sensitive NaCl cotransporter, NCC. Here, we show
that dietary potassium deficiency activates NCC,
even in the setting of high salt intake, thereby causing
sodium retention and a rise in blood pressure. The
effect is dependent on plasma potassium, which
modulates DCT cell membrane voltage and, in turn,
intracellular chloride. Low intracellular chloride stim-
ulates WNK kinases to activate NCC, limiting potas-
sium losses, even at the expense of increased blood
pressure. These data show that DCT cells, like adre-
nal cells, sense potassium via membrane voltage. In
the DCT, hyperpolarization activates NCC via WNK
kinases, whereas in the adrenal gland, it inhibits aldo-
sterone secretion. These effects work in concert to
maintain potassium homeostasis.
INTRODUCTION
Compared to diets consumed by our evolutionary ancestors, the
majority of people in the world today consume a diet relatively
high in salt (NaCl) and low in potassium (K+). A high dietary so-
dium (Na+) to K+ ratio is associated with hypertension, cardio-
vascular disease, and all-cause mortality. Although the DASH
diet, which lowers blood pressure regardless of NaCl intake,
does not specify K+ intake, it is replete with K+-rich foods, and
most investigators assume that a substantial portion of its bene-
ficial effects is mediated by K+ (Sacks et al., 2001). Recently, in
two studies of individuals from around the world, low K+ (LK)
intake was strongly associated with both higher blood pressureCand cardiovascular death (Mente et al., 2014; O’Donnell et al.,
2014). Yet, the mechanisms linking K+ intake and blood pressure
remain obscure.
Although Na+ reabsorption along all nephron segments con-
tributes to NaCl homeostasis, transport along the aldosterone-
sensitive distal nephron (ASDN) plays an especially important
role in K+ homeostasis. The ASDN includes a portion of the distal
convoluted tubule (DCT), the connecting tubule (CNT), and the
collecting duct (CD). The DCT is heterogeneous, comprising a
proximal portion, the DCT1, which primarily reabsorbs NaCl,
and a distal portion, the DCT2, where electroneurtral NaCl trans-
port coexists with electrogenic Na+ and K+ transport (Subrama-
nya and Ellison, 2014). The DCT1 does not secrete or reabsorb
substantial amounts of K+, so it has been surprising that genetic
diseases affecting the DCT are manifested primarily by disor-
dered K+ metabolism. Hypokalemia is common in Gitelman
and EAST/SeSAME syndromes, whereas hyperkalemia is a uni-
versal feature of familial hyperkalemic hypertension (FHHt, also
called pseudohypoaldosteronism type 2, or Gordon syndrome)
(Subramanya and Ellison, 2014).
The thiazide-sensitive Na-Cl cotransporter (NCC: SLC12A3)
is the predominant apical Na+ entry pathway in DCT1 cells.
Because DCT cells also control the delivery of NaCl into the
CNT, where the epithelial sodium channel (ENaC) mediates elec-
trogenic Na+ reabsorption andwhere K+ is secreted, they appear
to have a substantial, albeit indirect, role in K+ secretion. The
importance of the DCT in K+ secretion became apparent when
themolecular solution of FHHt led to the discovery of amolecular
switch comprising the with no lysine (WNK) kinases, Ste20p-
related proline alanine-rich kinase (SPAK), and oxidative stress
response 1 kinase (OxSR1). FHHt-causing disease mutations
appear to lock this switch in the on position, driving unrelenting
NCC activity, hyperkalemia, and hypertension. Although this
pathogenesis is clear, the nature of the physiological switch acti-
vator has remained elusive.
Dietary NaCl restriction activates NCC via angiotensin II and
aldosterone to preserve extracellular fluid (ECF) volume and
arterial pressure (Subramanya and Ellison, 2014). Yet, NCC
also responds to changes in dietary K+ intake. High KCl (HK)
diet suppresses (Frindt and Palmer, 2010; Rengarajan et al.,ell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc. 39
Figure 1. Effects of Dietary Potassium Intake on NCC Abundance
(A) Western blot of kidney from mice consuming HS/NK and HS/LK diets. The HS/LK diet increased the abundance of total NCC, pNCC-T53, and pNCC-T58
significantly (p < 0.01 for each by unpaired t test). NKCC2 was unaffected. Actin is a loading control.
(B) Plasma aldosterone and angiotensin II concentrations from the two groups. *p < 0.05 by unpaired t test.
(C) Western blot of kidney from AT1a
/ mice treated as in (A). pNCC is greater in HS/LK mice. p < 0.01 for pNCC-T53 by unpaired t test.
(D) Western blot of kidney from mice consuming NS/LK and HS/LK diets. Dietary salt loading increased the abundance of pNCC-T53 on a LK diet. p < 0.05 by
unpaired t test.
(E) Western blot for pNCC-T53 of urinary exosomes from mice consuming either HS/LK or HS/NK diets. The HS/LK diet increased pNCC-T53. p < 0.05 by
unpaired t test.
(F) Western blot for pNCC-T53 of urinary exosomes from volunteers consuming HS/LK and HS/NK diets. *p < 0.05 by paired t test.
(G) Dietary Na+, K+, and calorie content of volunteers consuming HS/LK and HS/NK diets. Bars represent mean ± SEM. See Table S1 for densitometry.2014; Sorensen et al., 2013; Vallon et al., 2009; van der Lubbe
et al., 2013), and low KCl intake increases, NCC activity (Casta-
n˜eda-Bueno et al., 2014; Vallon et al., 2009; Vitzthum et al.,
2014). These effects contribute to systemic K+ homeostasis
by altering Na+ delivery to K+ secretory segments. While the
WNKs are essential to maintain systemic K+ balance, in cell sys-
tems and in vitro, they are chloride (Cl)-sensitive kinases (Piala
et al., 2014; Ponce-Coria et al., 2008), which activate NCC when
intracellular [Cl] is low (Pacheco-Alvarez et al., 2006). Recently,
a WNK1 crystal structure showed that WNK1 binds Cl near the
catalytic lysine in subdomain 1, inhibiting its autophosphoryla-
tion and, in turn, activity (Piala et al., 2014).
Here, we sought to identify the physiological switch modu-
lating DCT function and NCC activity. The results show that die-
tary K+ intake, acting via plasma [K+], is a key NCC regulator.
Plasma [K+] signals NCC through changes in intracellular [Cl],
thereby modulating WNK kinases. Our experimental data and
in silico analysis suggest that plasma [K+] can enhance Cl efflux
from DCT cells through both electrogenic and electroneutral40 Cell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc.mechanisms. The results have implications for human disease
and public health.
RESULTS
Low Potassium Intake Activates NCC and Raises
Arterial Pressure
We first sought to determine whether ECF volume or K+ domi-
nates NCC activity in the context of combined interventions.
We confirmed that dietary NaCl loading suppresses NCC abun-
dance in mice (Figure S1A, available online). We then showed
that NCC and phosphorylated NCC (pNCC, as an index of acti-
vation) were more abundant in kidneys of mice consuming a
high-salt/low-K+ (HS/LK) diet than a high-salt/normal-K+ (HS/
NK) diet (Figure 1A and Table S1), suggesting that the K+ signal
overrides the ECF signal. Plasma aldosterone was not different
between the two groups, whereas plasma angiotensin II was
lower in the HS/LK group (Figure 1B). As the effect of LK diets
on pNCC was preserved in angiotensin II receptor type 1a null
Figure 2. Effects of Dietary Potassium
Intake on Urine Sodium and Blood Pressure
(A) Urine sodium excretion (24 hr) frommice on HS/
NK andHS/LK diets. *p < 0.05 by paired t test. Bars
represent mean ± SEM.
(B) Mean arterial pressure (MAP) recording (24 hr)
from mice on a HS/LK diet. Trace represents 2 hr
averages from three animals. Mice were main-
tained on a HS/NK diet for 1 week until time 0,
when they were switched to HS/LK. There was a
statistically significant increase in MAP during the
active period between day 0 and day 6 (Inset
shows mean ± SEM). *p < 0.05 by paired t test.
(C) Systolic blood pressure measurements for
wild-type and Slc12a3/mice on HS/NK and HS/
LK diets. **p < 0.01 by unpaired t test for the dif-
ference between the group differences.
(D) Urine calcium excretion (24 hr) from wild-type
and Slc12a3/ mice on HS/NK and HS/LK diets.
**p < 0.01 by unpaired t test for the difference be-
tween the group differences.mice (AT1a
/) (Figures 1C and S1B), AT1A receptors are not
required for these effects. The effect is also not general, as
HS/LK diet did not affect Na+-K+-2Cl cotransporter 2
(NKCC2) abundance (Figure 1A and Table S1). As dietary salt
loading magnifies the effects of dietary K+ on blood pressure,
we tested whether the effect of dietary K+ restriction on pNCC
is enhanced by high NaCl intake; Figure 1D shows that, during
dietary K+ deprivation, pNCC abundance is greater when mice
consume a high-NaCl rather than a normal-NaCl diet.
To estimate NCC activity noninvasively, we measured the
abundance of pNCC in urinary exosomes. This paralleled
changes in kidney pNCC, as it was greater in mice on a HS/LK
diet than those on a HS/NK diet (Figure 1E). To determine
whether humans exhibit a similar response to dietary K+ intake,
we analyzed pNCC in urinary exosomes (Hoorn et al., 2005; Pi-
sitkun et al., 2004) from volunteers who consumed a HS/LK
diet for 4 days followed by a HS/NK diet for 4 days. The abun-
dance of pNCC was significantly greater after the HS/LK diet
than after the HS/NK diet (Figure 1F). The diets had similar Na+
and calorie content, whereas dietary K+ differed (Figure 1G).
As these results suggested that dietary K+ deprivation activates
NCC, we measured urine Na+ excretion in mice. Although food
consumption was similar, body weight increased slightly (Figures
S2A and S2B), and urine Na+ excretion was lower on HS/LK than
on HS/NK (Figure 2A). To confirm that the LK diet also increased
arterial pressure, as reported by others (Vitzthum et al., 2014), we
showed that mean arterial pressure, measured telemetrically,
rose when mice were switched from HS/NK to HS/LK diet. The
rise in arterial pressure on the LK diet was primarily during the
active period (Figure 2B), also consistent with prior reports (Vitz-
thum et al., 2014). To determinewhether activation of NCCduring
LK diet contributed to the rise in blood pressure, we compared
the effects of diet inSlc12a3/mice andwild-type (WT) controls.Cell Metabolism 21, 39–In Slc12a3/ mice, blood pressure did
not rise during LK diet, whereas it did in
WT mice (Figures 2C and S2C). The
impact of genotype on response to LK
diet was significant.As modification of dietary K+ also affects urinary calcium
excretion in humans (Lemann et al., 1995), we sought to deter-
mine whether NCC was involved. We confirmed that mice
excreted more calcium when switched from a HS/NK to a HS/
LK diet (Figure 2D). This effect was not just absent in Slc12a3/
mice, it was reversed, so that HS/LK diet paradoxically reduced
urine calcium excretion (Figure 2D).
Plasma Potassium Signals the DCT via WNK
and SPAK/OxSR1
Plasma potassium was significantly lower in mice consuming a
LK, compared with a NK, diet (2.37 ± 0.13 versus 3.38 ±
0.04 mM). Yet, some have suggested that K+ must be ingested
orally to alter NCC (Sorensen et al., 2013). To test the role of
plasma [K+] without changing K+ intake, we manipulated plasma
[K+] pharmacologically with the K+-sparing diuretic amiloride.
Amiloride directly inhibits ENaC, leading to K+ retention, but it
does not affect NCC directly. Amiloride treatment of mice caused
substantial hyperkalemia and, as indicated by a higher hematocrit
(Figures 3A and 3B), ECF volume depletion. Despite the volume
depletion, which would be expected to stimulate NCC, amiloride
reduced both NCC and pNCC, suggesting again that the K+
signal overrides the ECF signal (Figure 3C and Table S2). Oppo-
site effects were observed for NKCC2, confirming that these phe-
nomena are specific to the DCT. As amiloride might have effects
unrelated to the changes in plasma [K+], we treated mice with a
LK diet along with amiloride to keep [K+] in the normal range.
This prevented the alterations in NCC and pNCC. Interestingly,
this also prevented the rise in hematocrit, suggesting that the ef-
fects of amiloride on ECF volume result from inhibiting Na+ trans-
port along sequential nephron segments (Figures 3A–3C).
In mice consuming a HS/LK diet, total renal SPAK and WNK4
abundance was significantly higher than that in mice consuming50, January 6, 2015 ª2015 Elsevier Inc. 41
Figure 3. Plasma Potassium Signals via WNK/SPAK Independent of Diet
(A) Plasma potassium levels frommice treated with vehicle (Veh), amiloride (Amil), and amiloride combined with LK diet. *p < 0.01 by unpaired t test corrected for
multiple comparisons.
(B) Hematocrit of mice treated with vehicle, amiloride, and amiloride combined with LK diet. *p < 0.01 by unpaired t test corrected for multiple comparisons.
(C) Western blot of kidney from mice treated with vehicle, amiloride, and amiloride combined with LK diet. All comparisons are significant. p < 0.01 for each by
unpaired t test (Veh versus Amil) corrected for multiple comparisons.
(D) Western blot of kidney from mice consuming HS/NK and HS/LK diets. p < 0.02 by unpaired t test for SPAK and WNK4. Actin loading control is same as
Figure 1A.
(E) Western blot of kidney from mice fed NS/NK and NS/LK diets. WNK4 abundance increased on NS/LK diet. p < 0.05 by unpaired t test.
(F) WNK4 and pSPAK/pOxSR1 immunofluorescence of DCT sections (dotted lines) from mice fed HS/NK and HS/LK diets.
(G) pWNK immunofluorescence of DCT sections (dotted lines) from mice fed HS/NK and HS/LK diets.
(H) SPAK and OxSR1 immunofluorescence of DCT (dotted lines) from mice fed HS/NK and HS/LK diets.
(I) Western blot of pNCC-T53 abundance from SPAK/ mice fed HS/NK and HS/LK diets. p < 0.01 by unpaired t test.
(J) Western blot of pNCC-T53 abundance from KS OxSR1/ mice fed HS/NK and HS/LK diets. p < 0.01 by unpaired t test.
(K) Western blot of pNCC-T53 abundance from SPAK/ and SPAK//KS OxSR1/mice fed HS/NK and HS/LK diets. pNCC-T53 abundance increased on HS/
LK in both genotypes (p < 0.01 by unpaired t test corrected for multiple comparisons) but increased less in SPAK//KS OxSR1/ mice. Two-way ANOVA
indicated p < 0.01 for diet, genotype, and interaction. Total NCC abundance increased in SPAK/ mice (p < 0.01 by unpaired t test corrected for multiple
comparisons), but not in SPAK//KS OxSR1/mice. Two-way ANOVA indicated p < 0.01 for diet and interaction. Bars represent mean ± SEM. See Table S2 for
densitometry.a HS/NK diet (Figure 3D). Similar effects were not observed for
OxSR1, WNK1, or WNK3 (Figure S3A), although our WNK1 anti-
body cannot the detect KS-WNK1, which is the predominant
WNK1 isoform in DCT. The same effect of dietary K+ on WNK442 Cell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc.abundance was observed when the dietary NaCl intake was
normal, indicating that the observed effects resulted from
changes in K+ intake alone (Figure 3E). Dietary K+ intake also
had substantial effects on kinase activation and localization in
the DCT. When mice consumed a HS/NK diet, WNK4 was
diffusely expressed, at low levels, along the distal nephron. On
a HS/LK diet, however, WNK4 localized to puncta, as confirmed
using two different, well-validated WNK4 antibodies (Figures 3F
and S3B). To confirm that this redistribution reflected WNK acti-
vation, we used an anti-phospho WNK antibody generated by
Alessi and colleagues (Thastrup et al., 2012) directed against a
motif containing an essential phosphorylated T-loop serine
shared by WNK1 and WNK4. As shown in Figure 3G, DCT pro-
files from mice on a HS/LK diet exhibited a substantial increase
in pWNK fluorescence intensity and punctate staining in com-
parison with DCT profiles from mice on a HS/NK diet.
To determine whether theWNK activation was associated with
SPAK and OxSR1 activation, we first demonstrated that SPAK
exhibited both an apical and a punctate cytoplasmic pattern on
a HS/NK diet. On a HS/LK diet, the localization appeared similar
but had greater intensity (Figure 3H). In contrast to this, OxSR1,
which exhibited a diffuse DCT staining pattern in mice on a HS/
NK diet, localized to both the apical membrane and puncta
on HS/LK, making it similar to SPAK (Figure 3H). To confirm
that this redistribution did reflect kinase activation, we used a
phosphospecific antibody recognizing residues phosphorylated
within the catalytic domain shared by SPAK and OxSR1
(pSPAK-T233/pOxSR1-T185) (Thastrup et al., 2012; Vitari et al.,
2005). Consistent with data presented thus far, the pSPAK/
pOxSR1 signal was of low intensity in mice consuming the HS/
NK diet. In contrast, mice consuming the HS/LK diet exhibited
an intense pSPAK/pOxSR1 signal, localized to the apical mem-
brane and cytoplasmic puncta (Figure 3F). This indicates that
on the HS/NK diet there is little activated WNK or SPAK/OxSR1
in the DCT but HS/LK diet activates both WNK and SPAK/
OxSR1, causing them to appear primarily in cytoplasmic puncta;
pSPAK/OxSR1 is also seen at the apical membrane, suggesting
a potential sequence of activation. When costained for WNK4
and pSPAK/pOxSR1, mice on high HS/LK exhibited substantial
colocalization within the puncta, but not at the apical membrane,
where only pSPAK/pOxSR1 was observed (Figure 3F).
As SPAK and OxSR1 are the major activators of NCC in vivo,
we used SPAK/ and kidney-specific (KS) OxSR1/ mice to
determine if either of these kinases is essential for the observed
changes in NCC. Both SPAK/ and KS OxSR1/ animals ex-
hibited increased pNCC abundance on a HS/LK diet, with per-
centage increases similar to what was observed in wild-type
mice (Figures 3I and 3J). Although mice lacking both SPAK
and kidney OxSR1 still exhibited increased pNCC abundance
on HS/LK compared with HS/NK (Figure 3K), the increase was
substantially blunted; analysis of variance indicated a significant
interaction between genotype and diet.
Extracellular Potassium Modulates NCC Directly
As plasma [K+] appeared to be the major determinant of NCC
activation, we tested whether NCC is modulated directly by
extracellular [K+], using cultured Flp-In NCC cells (Hoorn et al.,
2011). Cells cultured in LK medium had greater pNCC abun-
dance than cells cultured in NK (Figure 4A and Table S3). This ef-
fect appeared to be mediated by SPAK/OxSR1, as pSPAK/
pOxSR1 was also more abundant in the cells cultured in LK
(Figure 4B). The effects of LK were shown to be dependent on
endogenous WNK kinases because WNK1 or WNK3 siRNACknockdown (these are the major WNK kinases in HEK cells)
significantly attenuated the effects on pNCC and pSPAK/
pOxSR1 (Figures 4C and 4D).
As LK medium would be expected to hyperpolarize cells
(Weinstein, 2005), we tested whether changes in membrane po-
tential are required for effects on NCC. When we replaced K+
with Rb+, another cation that can traverse K+ channels and
should prevent any voltage change, pNCC and pSPAK/pOxSR1
did not change; in contrast, choline chloride supplementation did
not prevent effects on NCC (Figures 4E and S4A). Conversely,
treating the cells with the K+ channel inhibitor Ba2+, which depo-
larizes cells, decreased pNCC and pSPAK/pOxSR1 (Figure 4F).
In the DCT, the inwardly rectifying K+ channel, comprising
Kir4.1, likely with Kir5.1, appears to be the predominant conduc-
tive pathway for K+ exit along the basolateral membrane (Lourdel
et al., 2002; Zhang et al., 2014) (Figure S4B). When Kir4.1 muta-
tions, which reduce conductive activity, are present in the DCT, a
Gitelman-like tubulopathy, EAST/SeSAME syndrome, appears
(Bandulik et al., 2011; Reichold et al., 2010). When EAST syn-
drome mutant channels were expressed in our system, the
reversal potentials were less negative (Figures 5A and S4C),
and the pNCC abundance was lower (Figure 5B and Table S4)
than when wild-type channels were expressed.
Mutations in the selectivity filter of a related potassium channel
in adrenal cells were shown to cause hyperaldosteronism by
increasing the channel Na+/K+ permeability ratio (Choi et al.,
2011). As another test of the role of membrane voltage on
pNCC, we mutated the homologous amino acid residue in
Kir4.1 (G130). This mutated channel also depolarized the cells
and decreased pNCC (Figures 5A and 5C).
Extracellular Potassium Modulates NCC via Chloride
and WNK Kinases
In contemplating potential mechanisms for peritubular mem-
brane voltage to affect NCC activity, we turned to a model of
DCT cell function (Weinstein, 2005). According to the model, a
decrease in extracellular [K+] reduces [Cl] in the cell. As Cl
depletion activates NCC (Pacheco-Alvarez et al., 2006), and as
WNK kinases are activated at low ambient [Cl] (Piala et al.,
2014; Ponce-Coria et al., 2008), we tested the effects of LK incu-
bation on intracellular [Cl], using the Cl-sensing dye MQAE.
Baseline intracellular [Cl] was 77.6 mM, a value similar to that
reported previously for human embryonic kidney 293 (HEK293)
cells (Lamprecht et al., 2006). Culture in LK medium reduced
intracellular [Cl] significantly (Figure 6A). Conversely, intracel-
lular [Cl] increased with expression of each of the Kir4.1 mu-
tants compared with WT Kir4.1 (Figure 6B). To confirm this result
in amore relevant cell line, we tested the effects of LKmedium on
mDCT cells (Ko et al., 2012). Incubation of these cells in a LKme-
dium also reduced intracellular [Cl] significantly (Figure S5).
To test whether intracellular [Cl] must decline for LK to stim-
ulate NCC, we took three approaches. First, we showed that
cells incubated in high [Cl] medium exhibited an attenuated
pNCC response to LK exposure (Figure 6C and Table S5). We
next showed that the Cl channel/antiporter inhibitor, DIDS,
also attenuated the response to LK (Figure 6D). Finally, we
compared the effects of transfecting wild-type and mutant
ClC-K2, a Cl channel highly expressed along the DCT. Muta-
tions in the human ortholog, CLCNKB, cause Bartter syndromeell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc. 43
Figure 4. Effects of Extracellular Potassium on NCC in HEK Cells
(A) Western blot of HEK cells cultured in NK or LK medium. LK increased pNCC-T53 and pNCC-T58 abundance (p < 0.01 for both by unpaired t test).
(B) Western blot of HEK cells cultured in NK or LK medium. LK increased pSPAK/pOxSR1 abundance (p < 0.05 by unpaired t test).
(C) Western blot of HEK cells cultured in NK or LK medium following WNK1 siRNA knockdown or treatment with a negative control (scramble) siRNA. WNK1
abundance was significantly decreased following knockdown (p < 0.05 by unpaired t test). Cells in whichWNK1was knocked down exhibited a reduced increase
in pNCC-T53 and pSPAK/pOxSR1 following culture in LKmedium compared with cells that were transfected with a scramble siRNA. p < 0.05 for interaction of K+
treatment and WNK1 abundance by two-way ANOVA.
(D) Western blot of HEK cells cultured in NK or LK medium following WNK3 siRNA knockdown or treatment with a negative control (scramble) siRNA. WNK3
abundance was significantly decreased (p < 0.05 by unpaired t test). Cells in which WNK3 was knocked down exhibited a reduced increase in pNCC-T53 and
pSPAK/pOxSR1 following culture in LK medium compared with cells that were transfected with a scramble siRNA. p < 0.05 for interaction of K+ treatment and
WNK3 abundance by two-way ANOVA.
(E) Western blot of HEK cells cultured in NK, LK, or LK medium with Rb+ added. LK increased pNCC-T53 and pSPAK/pOxSR1 as before (p < 0.01 by unpaired t
test corrected for multiple comparisons), whereas adding Rb+ prevented these effects.
(F) Western blot of HEK cells cultured in mannitol (30 mM) or BaCl2 (10 mM). Treatment with BaCl2 decreased pNCC-T53 and pSPAK/pOxSR1 (p < 0.01 by
unpaired t test). See Table S3 for densitometry. Representative images are shown.type III, which can include the Gitelman-like features hypocalciu-
ria and hypomagnesemia. Compared with cells expressing WT
ClC-K2 channels, the LK-induced increase in pNCC was attenu-
ated when cells were transfected with Bartter syndrome type III
ClC-K2 mutants (Figures 6E, 6F, S6A, and S6B).
Recently, Piala et al. (2014) reported that Cl inhibits WNK1 by
binding to key residues in its catalytic domain. We therefore ex-
pressed WNK1 in which two of these residues, L369 and L371,
were mutated to phenylalanine (WNK1 L369F L371F). In LK me-
dium, pNCC was similar in cells expressing WT WNK1 and
mutant WNK1, indicating activated WNK1. In contrast, when
incubated in NK medium, the abundance of pNCC was lower
in cells expressing WT, but not in cells expressing mutant
WNK1 (Figure 6G). To confirm that LK medium activates
WNK1, we compared the abundance of activated (phosphory-
lated) WNK1 in cells transfected with wild-type WNK1 in NK
and LK medium and transfected with WNK1 L369F L371F in
NK medium (Figure 6H). The results confirm that LK medium ac-
tivates WNK1 in cells, just as mutation of the Cl binding sites
does.
The results indicate that plasma [K+], acting through intracel-
lular [Cl], likely affects NCC activity via WNK kinases; this effect
should have important physiological effects on distal K+ secre-
tion. We therefore introduced [Cl] sensitivity into the previously44 Cell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc.developed DCT model (Figure 7A). In the calculations for Fig-
ure 7, the fractional decrease in luminal membrane NCC activity
(compared with baseline) is 4-fold greater than the factional in-
crease in cytosolic [Cl] compared with baseline (see Experi-
mental Procedures). As in the prior model (black lines), reducing
peritubular [K+], within the physiological range, hyperpolarizes
the peritubular membrane (Figure 7A) and reduces intracellular
[Cl] (Figure 7B). Now, however, fluxes of Na+ andCl (Figure 7B)
are affected more substantially by the change in peritubular [K+].
When these effects are integrated along a modeled tubule, the
effect of peritubular [K+] to modulate Na+ delivery to the CNT is
greatly enhanced (Figure 7D).
DISCUSSION
WNK kinases comprise a molecular switch in the mammalian
distal nephron that modulates systemic electrolyte balance
and blood pressure. This switch is most potent within DCT cells,
where it acts through the intermediary kinases SPAK and OxSR1
to modulate NCC. When switched on, as in WNK4-FHHt, hyper-
trophy of the DCT ensues, along with increased pNCC abun-
dance (Subramanya and Ellison, 2014). When switched on by
anomalous WNK1 expression, as in WNK1-FHHt, pNCC abun-
dance is also increased (Vidal-Petiot et al., 2013). In Gitelman
Figure 5. Effects of Kir4.1 Mutant Channels
on Whole-Cell Reversal Potential and NCC
(A) Reversal potential of HEK cells expressing WT
Kir4.1 or mutant Kir4.1 channels. All mutants
depolarized cells compared with WT Kir4.1. *p <
0.01 by unpaired t test corrected for multiple
comparisons.
(B) Western blot of HEK cells expressing WT or
mutant Kir4.1 channels. All mutants decreased
pNCC-T53 compared with WT Kir4.1. p < 0.01 by
unpaired t test corrected for multiple comparisons.
The original image used for the first two panels is
shown in Figure S4D.
(C) Western blot of HEK cells expressing WT or
selectivity filter mutant Kir4.1 G130R. Expression
of the mutant decreased pNCC-T53 compared
with WT Kir4.1. p < 0.05 by unpaired t test. Bars
represent SEM. See Table S4 for densitometry.
Representative images are shown.syndrome, although the switch is likely on, it cannot prevent K+
losses because the effector, NCC, is defective, and K+ wasting
is therefore relentless. Although these clinical syndromes indi-
cate that WNKs, within the DCT, play a central role in systemic
K+ balance, the mechanisms and activators of this pathway
have been unclear. WNK kinases are Cl, but not K+, sensitive
(Piala et al., 2014; Ponce-Coria et al., 2008), and the DCT itself
secretes very little K+ (Subramanya and Ellison, 2014). The cur-
rent results show the dominant role that plasma [K+] plays in
regulating NCC and indicate that extracellular [K+] affects NCC
indirectly, by modulating intracellular [Cl]. They indicate that
plasma [K+] affects K+ secretion by altering Na+ delivery to the
CNT and suggest that the health benefits of dietary K+ supple-
mentation are dependent on NCC.
A blood pressure lowering effect of dietary K+ in humans was
reported in 1928 (Addison, 1928). Yet, dietary K+ has typically
received less attention than NaCl, perhaps because the tradi-
tional body fluid model for blood pressure control assigns pri-
macy to Na+. It is now clear that dietary K+ intake associates
inversely with blood pressure (Mente et al., 2014), often just as
strongly as dietary NaCl does. Recent reviews suggest myriad
and complex mechanisms for effects of K+ on arterial pressure,
including effects on the sympathetic nervous system, on the
vasculature, and on circulating factors, such as endogenous
ouabain; K+-induced natriuresis is rarely cited as essential
(Adrogue´ and Madias, 2007; He et al., 2010).
NCC is activated during ECF volume depletion via angiotensin
II, aldosterone, and renal nerves (Terker et al., 2014). The current
results confirm that dietary K+ intake also modulates pNCC
abundance and show that dietary K+ intake is more powerful in
this regard than ECF volume. These effects on NCC lead to blood
pressure changes, which are secondary to NCC activity. They
are mediated largely by changes in plasma [K+], as the effectsCell Metabolism 21, 39–were reproduced when plasma [K+] was
altered using drugs or diet, a conclusion
consistent with K+ infusion experiments
(Rengarajan et al., 2014). In contrast,
NKCC2, the major transporter mediatingNa+ reabsorption in the thick ascending limb (TAL), was affected
differently, suggesting that the DCT responds preferentially to
K+, while the TAL responds to other stimuli.
The results indicate that extracellular [K+], independent of hor-
monal effects, directly modulates the WNK-SPAK/OxSR1-NCC
axis. Our cell model provides insight into the mechanisms
involved, as reducing extracellular [K+] activated WNK1, SPAK/
OxSR1, and NCC in cells, and the effect required the WNK ki-
nases. In vivo, the effect of LK on pNCC abundance was sub-
stantially attenuated in mice lacking both SPAK and OxSR1,
supporting a role for these kinases. The remaining stimulation
observed in these animals could have resulted from WNK- and
Cab39-dependent, but SPAK-independent, activation (Ponce-
Coria et al., 2014). We documented that changes in membrane
voltage are involved, as maneuvers that alter membrane voltage
produced changes in pNCC abundance consistent with voltage
dependence. In contemplating how membrane voltage might
affect WNK kinases, we reflected on their sensitivity to Cl.
Recently, crystallographic analysis revealed that Cl binding to
WNK1 inhibits its autophosphorylation and activation (Piala
et al., 2014). The DCT model proposed by Weinstein predicts
that reducing peritubular [K+] lowers intracellular [Cl] (Wein-
stein, 2005). In that model, decreased peritubular [K+] could
enhance Cl exit both via peritubular potassium chloride
cotransport and, by hyperpolarizing the cell, via Cl channels.
We therefore used several approaches to determine whether
the effects of extracellular [K+] are mediated by changes in intra-
cellular [Cl]; all were consistent with a Cl-dependent effect.
Finally, we also show that overexpressing a WNK1 mutant with
altered Cl-binding residues abrogates effects of [K+] on NCC.
When we introduced Cl sensing into the DCTmodel (Figure 7A),
the potent effects of physiological variation in plasma [K+] on Na+
delivery to K+ secretory segments of the nephron become clear.50, January 6, 2015 ª2015 Elsevier Inc. 45
Figure 6. Role of Intracellular Chloride in Mediating K+ Effects on NCC
(A) Intracellular [Cl] in HEK cells in NK or LK medium. *p < 0.05 by unpaired t test.
(B) Relative intracellular [Cl] in HEK cells expressing WT Kir4.1 or Kir4.1 mutants. *p < 0.01 by unpaired t test corrected for multiple comparisons.
(C) Western blot of HEK cells cultured in normal [Cl] with mannitol or high [Cl] and also treated with NK or LK medium. p < 0.05 for the interaction between K+
treatment and Cl treatment by two-way ANOVA.
(D) Western blot of HEK cells treated with vehicle (DMSO) or DIDS and also treated with NK or LK medium. p < 0.05 for the interaction between K+ treatment and
drug treatment by two-way ANOVA.
(E) Western blot of HEK cells transfected withWT CLC-K2 or Bartter syndrome type III mutant CLC-K2 P124L channels and then cultured in NK or LKmedium. All
cells were also transfected with NCC and barttin. p < 0.05 for the interaction between K+ treatment and CLC-K2 genotype by two-way ANOVA.
(F) Western blot of HEK cells transfected withWTCLC-K2 or Bartter syndrome type III mutant CLC-K2 H357Q channels and then cultured in NK or LKmedium. All
cells were also transfected with NCC and barttin. p < 0.05 for the interaction between K+ treatment and CLC-K2 genotype by two-way ANOVA.
(G) Western blot of HEK cells transfected withWT orWNK1 L369F L371F (WNK1 Clmutant) and then cultured in LK or NKmedium. Cells expressing WTWNK1,
but not WNK1 Cl mutant, exhibited substantially lower pNCC-T53 abundance when cultured in NK compared with LK medium. p < 0.05 for the interaction
between K+ treatment and WNK1 genotype by two-way ANOVA. WNK1 was detected with anti-myc antibody. See Figure S6C for the original image.
(H) Western blot of HEK cells transfected with WTWNK1 cultured in NK or LK medium and WNK1 L369F L371F in NK medium. pWNK1 abundance increased in
both theWTWNK1 LK group and theWNK1 L369F L371F group. p < 0.05 for unpaired t test corrected formultiple comparisons. TotalWNK1 abundance obtained
before adding non-phospho-WNK1 peptide to block antibodies recognizing unphosphorylated WNK1. pWNK1 S382 abundance was obtained after addition of
the non-phospho-WNK1 peptide. Bars represent mean ± SEM. See Table S5 for densitometry.Although increasing NaCl delivery to distal segments may have
limited effects on K+ secretion during normokalemic euvolemia
(Hunter et al., 2014), the effects will be large when these seg-
ments are primed by exposure to aldosterone (Weinstein,
2012), as occurs during hyperkalemia.
Our in vivo and in vitro data are largely concordant, suggesting
that the HEK-NCC cell model is suitable for mechanistic studies,
but they are corroborated by our mDCT studies and by reports
that peritubular [K+] affects the reversal potential of intact DCT
segments (Lourdel et al., 2002). Recently, Wang and colleagues
showed that DCT cells from neonatal mice lacking KCNJ10 are
substantially depolarized (Zhang et al., 2014), supporting the
relevance of our results. Furthermore, Markadieu et al. (2012)
showed that incubating primary cultures of mouse DCT cells in46 Cell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc.low Cl hypotonic medium increases thiazide-sensitive 22Na
flux acrossmonolayers. Although Sorensen et al. (2013) reported
that high extracellular [K+] did not affect the pNCC abundance of
sorted mouse DCT cells in vitro, an effect may have beenmissed
for technical reasons.
Two important differences between HEK293 cells and DCT
cells should be emphasized, however. First, NCC activity is
driven largely by endogenous full-length WNK1 and WNK3 in
HEK cells, whereas WNK4 plays a central role in vivo (Takaha-
shi et al., 2014). Given the remarkable shift in WNK4 expression
pattern, the current data suggest that WNK4 is involved in
sensing [K+] in vivo, but they do not exclude roles for WNK1
and WNK3. Our WNK1 antibody does not detect kidney-spe-
cific WNK1, which comprises more than 90% of WNK1
Figure 7. Effects of Cl– Sensitivity on
Modeled DCT Function
(A–C) Membrane voltage (A), intracellular chloride
concentration (B), and transepithelial chloride flux
(JCl) (C) as functions of peritubular [K
+] concen-
tration. Circled are values at [K+]P, as shown in the
cartoon.
(D) The results of peritubular [K+] concentration on
sodium delivery to the CNT. The black lines are
taken from Weinstein (2005). The red lines show
results modified by the inclusion of NCC sensitivity
to intracellular [Cl].
(E) Cartoon showing the effects of plasma [K+] on
cells from the adrenal zona glomerulosa and renal
distal convoluted tubule. Directionally similar
changes in membrane voltage elicit opposite ef-
fects to activate or inhibit cell activity. Note that,
for simplicity, effects of angiotensin II have been
omitted. In this case, angiotensin II may have
similar effects to stimulate both cell populations.message in the DCT (Vidal-Petiot et al., 2013), and WNK3 did
accumulate in the puncta in the HS/LK mice (data not shown).
Additionally, as WNK kinases regulate ROMK, and probably
ENaC (McCormick and Ellison, 2011), effects on these chan-
nels might also contribute. Second, intracellular chloride in
HEK cells is substantially higher than in the DCT (Lamprecht
et al., 2006). All WNKs, however, contain the Cl-sensing motif
(Piala et al., 2014), suggesting that the same signals activate
both. Thus, our results help to resolve the paradox that cell-
based and in vitro studies have indicated that WNK kinases
are primarily Cl sensitive, whereas in vivo studies suggest
regulation by plasma K+.
The current work adds to evidence that NCC is activated by LK
diet and that the effects of LK diet on NCC activity are enhanced
by HS intake. While this conclusion seems counterintuitive, it
corroborates results from others (Vitzthum et al., 2014). Further,
it likely accounts for the observation that HK diet has a greaterCell Metabolism 21, 39–effect to lower pressure in humans during
high, compared with low, NaCl intake
(Sacks et al., 2001). As the effects of
HS/LK diet on arterial pressure are strik-
ingly blunted when NCC has been
deleted genetically (Figure 2C), NCC
plays an essential and nonredundant
role in the antihypertensive effects of die-
tary K+. As LK diet in humans also sti-
mulates NCC, the results are relevant to
human health.
Overall, our results indicate that dietary
K+ is the dominant force dictating NCC
activity. Recently, van der Lubbe et al.
(2013) reported that a LS/HK diet, the in-
verse manipulation to our dietary model,
decreased NCC levels and induced a
natriuresis, even in the setting of
continued low NaCl intake. This brings
the total to three models where K+ over-
rides ECF volume and the renin-angio-tensin-aldosterone system (RAAS) status to dictate NCC activity
(van der Lubbeet al., 2013; Vitzthumet al., 2014). Although effects
of LK are consistent between studies, the effects of HK depend
on the accompanying anion (Castan˜eda-Bueno et al., 2014).
In EAST/SeSAME syndrome, ECF volume depletion and hypo-
kalemia should activate NCC (Bandulik et al., 2011). Instead, the
effects of K+-channel dysfunction on membrane voltage, and in
turn intracellular [Cl], suppress NCC activity, a finding consis-
tent with decreased pNCC abundance in KCNJ10/ mice
(Zhang et al., 2014). The current results also help to explain the
phenotype of individuals with Bartter syndrome type III, caused
by mutations in CLCNKB. In contrast to other forms of Bartter
syndrome, where NCC is strikingly activated (Wagner et al.,
2008), the individuals exhibit a combined loop-DCT phenotype,
with suppressed DCT activity. Here, we show that expression
of disease-causing CLC-K2mutants prevents LK from activating
NCC, likely because intracellular [Cl] remains high.50, January 6, 2015 ª2015 Elsevier Inc. 47
Prevention of recurrent nephrolithiasis often includes supple-
mental dietary K+. Potassium deficit enhances urinary calcium
excretion, an effect dependent on ECF volume (Lemann et al.,
1995). The current results show that NCC activation plays an
essential role in the effects of dietary K+ on urinary calcium
excretion; not only was K+-induced calcium retention lacking in
Slc12a3/mice, but the effects of dietary K+ on calcium excre-
tion were reversed. This suggests that effects of dietary K+ sup-
plementation and thiazide diuretics on the same transport
pathway, NCC, mediate their similar, and complementary, ef-
fects on hypercalciuria.
Lastly, the results establish the DCT as a renal K+ sensor,
which acts in concert with the adrenal gland to preserve K+ ho-
meostasis. In this respect, DCT cells and adrenal zona glomeru-
losa cells both sense the same signal, membrane voltage, but
respond in opposite directions (Figure 7C). A rise in plasma
[K+] depolarizes zona glomerulosa cells, as the membrane
conductance is dominated by KCNJ5 and TASK-2. This opens
voltage-activated calcium channels and stimulates aldosterone
production and release. In the kidney, a rise in plasma [K+] also
depolarizes DCT cells, as the basolateral membrane conduc-
tance is dominated by KCNJ10. In this case, however, the
ensuing rise in intracellular [Cl] binds toWNK kinases, switching
them into the off position and shutting down NCC. To produce
kaliuresis, events in adrenal and DCT must occur pari passu.
This is assured by having the same signal, extracellular [K+],
regulate both cell types. As adrenal cells respond to the ECF vol-
ume signal angiotensin II, DCT cells likely do too. In this case,
however, the responses in the two organs must be consonant.
Thus Cl-sensing WNK kinases, which likely evolved to protect
cell volume and osmolality (McCormick and Ellison, 2011), now
play central roles in systemic K+ balance in mammals. That sys-
temic K+ balance is defended more avidly than NaCl balance
(see above and Vitzthum et al., 2014) indicates its physiological
importance. As hyperkalemia is often amajor factor limiting ther-
apeutic RAAS blockade in humans, these insights provide op-
portunities to intervene.
EXPERIMENTAL PROCEDURES
Antibodies
The antibodies employed have all been characterized and reported before.
Details are provided in the Supplemental Information.
Animals
Studies were approved by Oregon Health and Science University’s Animal
Care and Usage Committee (Protocol IS918). All mice were 12–24 weeks
old, 25–30 g, and had a C57Bl/6 background, except for NCC/mice, which
were on a BALB/c background. All strains are backcrossed to the appropriate
wild-type mice every ten generations to maintain genetic backgrounds. Addi-
tional details can be found in the Supplemental Information.
PCR Genotyping
Tail-snip genotyping for NCC/ (Schultheis et al., 1998), KS OxSR1/, and
AT1a
/ mice (Terker et al., 2014) used previously reported primers. A previ-
ously reported approach was used (McCormick et al., 2011) to genotype
SPAK/ mice. Details are provided in the Supplemental Information.
Animal Diets
All diets used in K+ studies were prepared in our lab bymodifying a K+-deficient
diet (Harlan Laboratories K+-deficient diet; TD.88239). High salt was obtained
by adding NaCl to make a 6% NaCl diet. Low-K+ diets had no additional K+48 Cell Metabolism 21, 39–50, January 6, 2015 ª2015 Elsevier Inc.added, and normal K+ was obtained by adding KCl to make a 1% K+ diet.
Low-NaCl diet used was also purchased from Harlan Laboratories (Na+-defi-
cient diet; TD.90228).
Blood Pressure Measurement
Noninvasive systolic blood pressures weremeasured with tail cuffs using volu-
metric pressure recording (CODA-16; Kent Scientific); details are provided in
the Supplemental Information. Radiotelemetry studies were performed using
carotid probes. Animals were allowed to recover from surgery for 1 week, dur-
ing which the animals were fed a HS/NK diet. Following the 7-day recovery
period, animals were changed to a HS/LK diet.
Blood Analysis
Whole blood was collected via cardiac puncture following indicated treat-
ments. Plasma K+ and hematocrit values were obtained by iSTAT just after
collection by loading whole blood into a chem 8 cartridge (Abbot Point of
Care). The remaining blood was centrifuged for 5 min at 2000 3 g in heparin-
ized tubes. Plasma was removed and frozen at80C until future use. Plasma
aldosterone was measured by ELISA (IBL America), and plasma angiotensin II
was measured by EIA (Phoenix Pharmaceuticals).
Urinary Electrolyte Measurement
Mice were maintained on HS/NK for 7 days. For the final 3 days, mice were
individually housed in metabolic cages, and urine was collected under wa-
ter-saturated light mineral oil over the final 24 hr period. Animals were then
switched to the HS/LK diet, and the procedure was repeated. Body weight
was monitored during the metabolic cage period. Urine was frozen at 20C
until Na+ was measured by flame photometry and Ca2+ by o-Cresolphthalein
Complexone method (Pointe Scientific).
Urinary Exosome Preparation in Mice
Wild-type animals were fed either a high-salt/normal-K+ or high-salt/low-K+
diet for 7 days. For the last 3 days, animals were housed in metabolic cages,
and urine was collected under water-saturated light mineral oil over the final
24 hr period. Exosomes were then obtained from one-third of the total urine
volume according to a previously published protocol (van der Lubbe et al.,
2012). The entire exosome preparation was then loaded onto a 3%–8% Tris-
acetate gel (Invitrogen), and western blot was performed.
Immunoblotting
Mice were maintained on indicated diets for 7–10 days or treated with amilor-
ide (50 mg/l drinking water) for 5–7 days, after which kidneys were harvested
and snap-frozen in liquid nitrogen. Kidneys were then homogenized on ice in
chilled buffer containing protease and phosphatase inhibitors. Protein (20–
80 mg) was separated on a 4%–12% Bis-Tris gel or a 3%–8% Tris-acetate
gel (Invitrogen). Densitometry was performed using ImageJ (http://rsbweb.
nih.gov/ij/).
Immunofluorescence
Mice were anesthetized and kidneys perfusion-fixed by retrograde abdominal
aortic perfusion of 3% paraformaldehyde in PBS (pH 7.4). After cryoprotection
with 800 mOsm sucrose and freezing, 5 mm sections were cut and stored at
80C until use. Details are provided in the Supplemental Information.
Cell Culture
Flp-In NCC cells as reported (Hoorn et al., 2011) were used for experiments in
which only NCC expression was required. NCC was cotransfected in HEK293
cells using Lipofectamine (Invitrogen) in studies that required coexpression of
NCC with other proteins or in siRNA studies. Additional information about
transfection and conditions is provided in the Supplemental Information.
Intracellular Cl– Measurement
Cells were plated in poly D-Lysine coated 96-well plates on day 0 (Becton
Dickinson Labware). On day 1, the indicated medium was added, and mea-
surements were performed on day 2. For Kir4.1 experiments, stably trans-
fected cell lines were made by subcloning wild-type or mutant Kir4.1 into
pIRES-puro3 (Clontech) and selecting cells with puromycin (1 ug/ml). Stable
cells were plated in normal K+ Dulbecco’s modified Eagle’s medium
(DMEM), and Clwasmeasured. Additional details are provided in the Supple-
mental Information.
Human Studies
Human studies were approved by Oregon Health & Science University’s Inter-
nal Review Board (Protocol IRB9934). Volunteers consumed a high-salt/low-
K+ diet and a high-salt/K+-replete diet, based on food package nutritional
facts label or the USDA nutrient database (http://ndb.nal.usda.gov/), each
for a 4-day period. Additional information is included in the Supplemental
Information.
Measurement of K+ Reversal Potentials
HEK293T cells (American Type Culture Collection) were grown in DMEM (Invi-
trogen) supplemented with 10% FBS (Invitrogen) in 5% CO2 and 95% air at
37C. Cells were grown to 50%–70% confluence for transfection, and the cor-
responding cDNAs were simultaneously applied to the cells using TurboFect
transfection reagent (Fermentas).
For the measurement of K+ reversal potential, an Axon 200A patch-clamp
amplifier was used. We carried out the perforated whole-cell patch-clamp ex-
periments on Kcnj10/mutant transfected HEK293T cells at room temperature.
Details are provided in the Supplemental Information.
Model of Distal Convoluted Tubule Cells
Model calculations were performed using the DCT model of Weinstein (2005),
with modified model parameters provided in the Supplemental Information.
Statistical Analyses
All values are expressed as mean ± SEM. Between-group comparisons were
performed using Student’s t test (paired or unpaired, as indicated in figure
legends), corrected for multiple comparisons when appropriate. Variable inter-
actions were determined by two-way ANOVA. Body weight was analyzed by
one-way ANOVA with repeated measures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.12.006.
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